AstraZeneca’s TAGRISSO Combo Delivers Survival Advantage In EGFRm NSCLC Phase III Trial

(RTTNews) – AstraZeneca (AZN) announced positive results from the final overall survival (OS) analysis of the…

Can Using the Light Phone III Help Cure ‘Brain Rot’?

Dear readers, I have a confession: I am suffering from an ailment that the younger ones…